DiaMedica Therapeutics to Participate in 11th Annual Craig-Hallum Alpha Select Conference
November 11 2020 - 8:30AM
Business Wire
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage
biopharmaceutical company developing novel treatments for chronic
kidney diseases and neurological disorders, today announced its
President and CEO, Rick Pauls, and Chief Financial Officer, Scott
Kellen, are scheduled to participate in the Craig-Hallum Alpha
Select Conference, which is being held as a virtual event on
November 17, 2020.
Meetings will take place virtually on November 17, 2020 given
the ongoing call for social distancing due to the Covid-19
pandemic. Interested institutional investors should contact their
Craig-Hallum sales representative to schedule a meeting.
About DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a clinical stage
biopharmaceutical company focused on developing novel treatments
for chronic kidney diseases and neurological disorders. DiaMedica’s
shares are listed on The Nasdaq Capital Market under the trading
symbol “DMAC.”
For more information, please visit www.diamedica.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201111005155/en/
Scott Kellen Chief Financial Officer Phone: (763) 496-5118
skellen@diamedica.com
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
DiaMedica Therapeutics (NASDAQ:DMAC)
Historical Stock Chart
From Apr 2023 to Apr 2024